Drugs / Qidan Xiaoke Granules
Qidan Xiaoke Granules
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07616544 | Jul 2026 → Jun 2028 expected | coronary artery disorder | Liu Qiang | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qidan Xiaoke Granules | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07616544 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The results will help determine whether this herbal formula can be recommended as an effective and safe rehabilitation treatment for patients after coronary revascularization.” NCT07616544 ↗ |
| Route | Oral | “Qidan Xiaoke Granules orally, one sachet twice daily for 12 consecutive weeks.” NCT07616544 ↗ |